Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sienna signs lease for new premises to facilitate the execution of its strategic goal to become an IVD Hub (ASX:SDX)

Sienna advances its plans to become a hub for IVD test development and commercialisation New premises are located near CSIRO and the Monash Technology Precinct New manufacturing fac...read more

Sequoia Financial Group Announce Notice of Annual General Meeting/Proxy Form (ASX:SEQ)

Notice of 2019 Annual General Meeting to be held on Wednesday, 30 October 2019. Explanatory Memorandum for the Notice of Annual General Meeting. Notice of the 2019 Annual General Meeting to be h...read more

SUDA Pharmaceuticals Announce Managing Director & CEO Resignation (ASX:SUD)

Perth, Australia – 24 September 2019: SUDA Pharmaceuticals Limited (ASX: SUD), a leader in oro-mucosal drug delivery, advises that Managing Director and Chief Executive Officer, Mr Stephen Carte...read more

Sienna Receives R&D Tax Incentive Refund (ASX:SDX)

Melbourne, Australia, 23 September 2019: Sienna Cancer Diagnostics Ltd, (ASX:SDX) (“Sienna” or “the Company”), a medical technology company developing and commercialising innov...read more

Sequoia Financial Group Announce Change of Director's Interest Notice (ASX:SEQ)

Appendix 3Y Change of Directors's Interest Notice - Kevin James Pattison For further information please download the attached PDF:

Sequoia Financial Group Announce Change in Director's Interest Notice (ASX:SEQ)

Appendix 3Y Change of Director's Interest Notice For further information please download the attached PDF:

Sequoia Financial Group Announce Change in Director's Interest Notice (ASX:SEQ)

Appendix 3Y Change in DIrector's Interest Notice For further information please download the attached PDF:

Sequoia Financial Group Announce Change of Director's Interest Notice (ASX:SEQ)

Appendix 3Y Change of Director’s Interest Notice For more information please download the attached PDF:

SUDA Pharmaceuticals release Article on Anagrelide (ASX:SUD)

Article on Anagrelide PERTH, AUSTRALIA - 29 August 2019; SUDA Pharmaceuticals Ltd (ASX:SUD), a leader in oro-mucosal drug delivery ("SUDA"). is pleased to announce that Research Outreach ...read more

Sequoia Announce On-Market Buy-Back & Appendix 3C (ASX:SEQ)

Sequoia Financial Group Limited (ASX: SEQ) (Company or Sequoia) pleased to announce that the Directors have determined that the Company will conduct an on-market buy-back of up to a maximum of 11,919,...read more

Sequoia Financial Group Announce FY2019 results (ASX:SEQ)

Investor Presentation FY2019 results To view the presentation please download the attached PDF:

Sequoia Announce Appendix 4E and Annual Report Year Ended 30 June 2019 (ASX:SEQ)

Appendix 4E Preliminary Final Report For further information please download the attached PDF:

Sequoia Financial Group Appendix 4G and Corporate Governance Statement (ASX:SEQ)

Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations For further information please download the attached PDF:

Sequoia Financial Group Announce Corporate Update Interview (ASX:SEQ)

Transcript of Finance News Network Interview with Sequoia CEO and Executive Director Sequoia Financial Group Limited (ASX:SEQ or Sequoia) provides the following transcript of a video interview with...read more

Sequoia Financial Group Limited acquisition of Libertas Financial Planning (ASX:SEQ)

Sequoia Financial Group Limited (ASX: SEQ) (“SEQ”, “Sequoia” or “the Company”) is pleased to announce the acquisition of Libertas Financial Planning Pty Ltd (Libe...read more

Viewing: 1 - 15 of 200 Previous | Next